175th Meeting of the ACNFP 11th and 12th February 2026 Agenda
On this page
Skip the menu of subheadings on this page.ACNFP/AG/175
Advisory Committee on Novel Foods and Processes
The 175th meeting of the ACNFP will be held as a two-day event at 10:00am on the 11th and 12th of February 2026 at Broadway House, Tothill St., Westminster, London, SW1H 9NQ by invite only and on Microsoft Teams (online & dial in).
Members are reminded of the need to announce any commercial interests in the business of the Committee prior to the discussions on each item.
In accordance with agreed procedures, the Secretariat is duty bound to keep a record of the names of Members who have declared interests at meetings of the Committee, giving dates, names of relevant products and companies, details of the interest declared, and whether the Member took part in the proceedings.
ACNFP Secretariat
January 2026
175th Meeting of the ACNFP - 11th February 2026 (Day 1) Agenda
1. Apologies and Announcements
2. Welcome
3. 174th Meeting Minutes
4. Matters Arising
5. Fermotein RP1215 - The Committee will consider the response from the applicant to support progression of the review of this full novel food application. ACNFP/175/01
6. EFSA 2024 guidance - The Committee will review the updated EFSA novel food guidance and provide feedback on whether it is appropriate to provide the basis for assessment of GB applications. ACNFP/175/02
7. Draft precision fermentation advisory document – The Committee will provide feedback on a draft advisory document to assist applicants in the preparation of high-quality precision fermented novel food applications. ACNFP/175/03
8. Draft Committee Advice Document (CAD) template for precision fermented novel foods – The Committee will provide feedback on the CAD template that has been prepared for use in compiling information on precision fermented novel foods. ACNFP/175/04
9. Genetically modified Maize Bt11 × MIR162 × MZIR098 × DP4114 × NK603, RP2288 (reserved business) - The Committee will review the draft safety assessment outcome developed and agreed by the PGT Subcommittee. ACNFP/175/05
10. Genetically modified Soybean MON94313, RP2261 (reserved business) - The Committee will review the draft safety assessment outcome developed and agreed by the PGT Subcommittee. ACNFP/175/06
11. Genetically modified Soybean COR23134 RP2310 (reserved business) - The Committee will review the draft safety assessment outcome developed and agreed by the PGT Subcommittee. ACNFP/175/07
12. Items for Information
12.1 Update from Novel Foods Policy Team
12.2 Update from GM Policy Team
12.3 SACs update
12.4 Decision Panel update
13. AOB
12th February 2026 (Day 2) Agenda
14. Introduction to Cell-Cultivated Products (CCP) policy - CCP policy team will give an overview of policy considerations for CCP novel food applications.
15. Introduction to CCP novel food applications - FSA Sandbox team will give an overview of the key technical considerations and common themes observed across CCP novel food application dossiers.
16. Cultivated chicken biomass RP2218 (reserved business) - The Committee will review this full CCP novel food application for the first time and identify key considerations for the assessment and any data gaps. ACNFP/175/08
17. Cell-cultivated duck RP2241 (reserved business) - The Committee will review this full CCP novel food application for the first time and identify key considerations for the assessment and any data gaps. ACNFP/175/09
Date of next meeting – 23rd April 2026